Nothing Special   »   [go: up one dir, main page]

SE8603812D0 - Administration of liposomes to mammals - Google Patents

Administration of liposomes to mammals

Info

Publication number
SE8603812D0
SE8603812D0 SE8603812A SE8603812A SE8603812D0 SE 8603812 D0 SE8603812 D0 SE 8603812D0 SE 8603812 A SE8603812 A SE 8603812A SE 8603812 A SE8603812 A SE 8603812A SE 8603812 D0 SE8603812 D0 SE 8603812D0
Authority
SE
Sweden
Prior art keywords
lipid
based solid
mammals
liposomes
solid material
Prior art date
Application number
SE8603812A
Other languages
English (en)
Inventor
B I Axelsson
U K Bystrom
C M O Dahlbeck
L A Kellstrom
P-G Nilsson
J W Trofast
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE8603812A priority Critical patent/SE8603812D0/sv
Publication of SE8603812D0 publication Critical patent/SE8603812D0/sv
Priority to ZA876641A priority patent/ZA876641B/xx
Priority to EP87850273A priority patent/EP0260241A1/en
Priority to HU874531A priority patent/HU198835B/hu
Priority to EP87906023A priority patent/EP0282537A1/en
Priority to JP62505390A priority patent/JPH01500668A/ja
Priority to PCT/SE1987/000401 priority patent/WO1988001862A1/en
Priority to DE1987906023 priority patent/DE282537T1/de
Priority to AU79133/87A priority patent/AU603139B2/en
Priority to NZ221732A priority patent/NZ221732A/xx
Priority to CA000546527A priority patent/CA1256798A/en
Priority to IE872453A priority patent/IE872453L/xx
Priority to DK247388A priority patent/DK247388A/da
Priority to NO882077A priority patent/NO882077L/no
Priority to KR1019880700519A priority patent/KR880701540A/ko
Priority to FI882221A priority patent/FI882221A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8603812A 1986-09-12 1986-09-12 Administration of liposomes to mammals SE8603812D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE8603812A SE8603812D0 (sv) 1986-09-12 1986-09-12 Administration of liposomes to mammals
ZA876641A ZA876641B (en) 1986-09-12 1987-09-04 A new system for administration of liposomes to mammals
HU874531A HU198835B (en) 1986-09-12 1987-09-08 Process for producing pharmaceutical compositions forming liposomes
PCT/SE1987/000401 WO1988001862A1 (en) 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals
AU79133/87A AU603139B2 (en) 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals
EP87906023A EP0282537A1 (en) 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals
JP62505390A JPH01500668A (ja) 1986-09-12 1987-09-08 哺乳動物にリポソームを投与するための新規システム
EP87850273A EP0260241A1 (en) 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals
DE1987906023 DE282537T1 (de) 1986-09-12 1987-09-08 Neues system zur verabreichung von lisposomen an saeugetiere.
NZ221732A NZ221732A (en) 1986-09-12 1987-09-09 A system for administration of dry lipid-based solid material in a particulate form
CA000546527A CA1256798A (en) 1986-09-12 1987-09-10 System for administration of liposomes to mammals
IE872453A IE872453L (en) 1986-09-12 1987-09-11 A new system for administration of liposomes to mammals
DK247388A DK247388A (da) 1986-09-12 1988-05-06 System til indgift af liposomer til pattedyr
NO882077A NO882077L (no) 1986-09-12 1988-05-11 Nytt system for administrasjon av liposomer til pattedyr.
KR1019880700519A KR880701540A (ko) 1986-09-12 1988-05-11 포유류에 리포좀을 투여하기 위한 신규시스템
FI882221A FI882221A0 (fi) 1986-09-12 1988-05-11 Nytt system foer administrering av liposomer till daeggdjur.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603812A SE8603812D0 (sv) 1986-09-12 1986-09-12 Administration of liposomes to mammals

Publications (1)

Publication Number Publication Date
SE8603812D0 true SE8603812D0 (sv) 1986-09-12

Family

ID=20365554

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603812A SE8603812D0 (sv) 1986-09-12 1986-09-12 Administration of liposomes to mammals

Country Status (13)

Country Link
EP (2) EP0260241A1 (sv)
JP (1) JPH01500668A (sv)
KR (1) KR880701540A (sv)
AU (1) AU603139B2 (sv)
CA (1) CA1256798A (sv)
DK (1) DK247388A (sv)
FI (1) FI882221A0 (sv)
HU (1) HU198835B (sv)
IE (1) IE872453L (sv)
NZ (1) NZ221732A (sv)
SE (1) SE8603812D0 (sv)
WO (1) WO1988001862A1 (sv)
ZA (1) ZA876641B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507090A (ja) * 1990-05-08 1993-10-14 リポサーム テクノロジー インコーポレイテッド 直接噴霧乾燥された薬剤/脂質粉末組成物
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
JPH07503952A (ja) * 1992-02-12 1995-04-27 ジヤンセン・シラグ・ソチエタ・ペル・アチオニ リポソームピロキシカム組成物
EP0625898B1 (en) * 1992-02-12 1996-05-15 JANSSEN-CILAG S.p.A. Liposomal piroxicam formulations
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
MX9706449A (es) 1995-02-28 1997-11-29 Hoechst Marion Roussel Inc Composicion farmaceutica para compuestos de piperidinalcanol.
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
TW497974B (en) * 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
ID22891A (id) * 1997-08-26 1999-12-16 Hoechst Marion Roussel Inc Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6599889B2 (en) * 1997-12-24 2003-07-29 Methylgere, Inc. Acyl phosphonate inhibitors of β-lactamases
WO1999033850A1 (en) * 1997-12-24 1999-07-08 Methylgene, Inc. NOVEL β-LACTAMASE AND DD-PEPTIDASE INHIBITORS
CN1303271A (zh) * 1998-05-27 2001-07-11 尤罗塞尔蒂克股份有限公司 施用于下呼吸道的消炎剂,特别是抗菌剂和/或促进伤口愈合活性剂的制剂
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
GB9902527D0 (en) 1999-02-04 1999-03-24 Phares Pharm Res Nv Compositions
US6630169B1 (en) 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
JP5616565B2 (ja) 1999-05-27 2014-10-29 ユーロ−セルティック エス. ア. 抗炎症剤を適用するための製剤
US7364749B1 (en) 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1296651B2 (en) * 2000-06-27 2019-07-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
AU2001269261B2 (en) * 2000-06-27 2005-11-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
US7141236B2 (en) 2000-07-28 2006-11-28 Nektar Therapeutics Methods and compositions for delivering macromolecules to or via the respiratory tract
JP2004528339A (ja) * 2001-04-26 2004-09-16 ネクター セラピューティクス 気道に対して又は気道を介して高分子を送達するための新規方法及び組成物
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
EP1954243A2 (en) * 2005-10-26 2008-08-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposomes and uses thereof
WO2009073843A1 (en) * 2007-12-06 2009-06-11 Cytotech Labs, Llc Inhalable compositions having enhanced bioavailability
SG183508A1 (en) 2010-03-12 2012-10-30 Berg Pharma Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
CN104997634A (zh) 2010-04-09 2015-10-28 帕西拉制药有限公司 用于配制大直径合成膜囊泡的方法
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
EP2598128B1 (en) 2010-07-28 2018-03-28 Life Technologies Corporation Anti- viral azide-containing compounds
EP2720680B1 (en) 2011-06-17 2020-02-12 Berg LLC Inhalable pharmaceutical compositions
CN108977412A (zh) 2012-01-26 2018-12-11 生命科技公司 用于提高病毒感染性的方法
HU231309B1 (hu) 2014-02-25 2022-11-28 Darholding Kft. Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra
CN111729087A (zh) * 2020-07-24 2020-10-02 成都大学 一种选择性β2受体激动剂的脂质修饰物及其制备方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
GB1575344A (en) * 1978-03-03 1980-09-17 Ici Ltd Method for the manufacture of liposome composition
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
DE3686025T2 (de) * 1985-05-22 1993-01-07 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.

Also Published As

Publication number Publication date
HUT47840A (en) 1989-04-28
HU198835B (en) 1989-12-28
AU603139B2 (en) 1990-11-08
FI882221A (fi) 1988-05-11
WO1988001862A1 (en) 1988-03-24
KR880701540A (ko) 1988-11-03
DK247388D0 (da) 1988-05-06
CA1256798A (en) 1989-07-04
IE872453L (en) 1988-03-12
EP0260241A1 (en) 1988-03-16
AU7913387A (en) 1988-04-07
NZ221732A (en) 1990-08-28
FI882221A0 (fi) 1988-05-11
ZA876641B (en) 1988-03-14
EP0282537A1 (en) 1988-09-21
DK247388A (da) 1988-05-06
JPH01500668A (ja) 1989-03-09

Similar Documents

Publication Publication Date Title
SE8603812D0 (sv) Administration of liposomes to mammals
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
MY132999A (en) New formulation for inhalation
EE03222B1 (et) Inhaleeritavad ravimpreparaadid, protsess nende valmistamiseks ja seade nende kasutamiseks
MY8600471A (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof
DK0656207T3 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
DK0871430T3 (da) Pulvere og anvendelse deraf i tørpulverinhalatorer
EP0458894A4 (en) LIPID EXCIPIENT FOR NASAL ADMINISTRATION AND OTHER LOCAL APPLICATIONS.
ATE257699T1 (de) Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, mit formoterol
EE03998B1 (et) Inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml
SE8601457D0 (sv) Compositions of liposomes and b?712-receptor active substances for inhalation
NL1008020A1 (nl) Nieuwe formulering voor inhalatie.
DE68906205D1 (de) Kosmetische un paramedizinische praeparate.
SE8800182D0 (sv) Anvendning av alkylglycerol for framstellning av ett lekemedel
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
SE8800026L (sv) Anvaendning av alkylglycerol foer framstaellning av laekemedel
TH16088A (th) สูตรผสมสำหรับการสูดดม
MY8500525A (en) Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity